ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3020

IL-21 Abrogates CD4+CD25+FOXP3+ Treg Differentiation in Part By Suppressing Treg GATA-3 Expression in SLE

Hiroshi Kato1 and Andras Perl2, 1Division of Rheumatology/Internal Medicine, SUNY Upstate Medical University, Syracuse, NY, 2Department of Medicine, SUNY Upstate Medical University, Syracuse, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cytokines, systemic lupus erythematosus (SLE) and transcription factor, T-Regulatory Cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: T cell Biology and Targets in Autoimmune Disease Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Previous studies point to qualitative and quantitative Treg insufficiencies underlying aberrant T-cell activation in SLE. GATA-3 is critical in lineage commitment and functions of murine Treg, whereas IL-21 tips the balance from Treg towards Th17 differentiation through STAT3 phosphorylation in mice. IL-21 and IL-21 receptor polymorphisms confer risk for SLE. However, roles of GATA-3 in lupus Treg biology and mechanisms by which IL-21 regulates human Treg development remain undefined.

Methods: CD3+ T cells were isolated from 9 pairs of matched SLE and healthy control (HC) subjects. A part of the CD3+ T cells were stained with CD4, CD25, FOXP3, and GATA-3. The remainder was cultured in RPMI culture media with 10% FCS in the presence of plate-bound anti-CD3, soluble anti-CD28 with/without 100 nM rapamycin. After 3 days in culture, IL-21 secretion in the supernatants was quantified by LUMINEX assay. Naïve CD4+ T cells were isolated from 5 pairs of matched SLE and HC subjects and cultured for 3 days in the presence of anti-CD3/CD28, TGF-β, and IL-2 with/without IL-21. A portion of cells were stained with CD25, FOXP3, and GATA-3 to determine the frequency of CD4+CD25+FOXP3hi Tregs and GATA-3 expression in the CD4+CD25+FOXP3+ Tregs by flow cytometry. Cell lysates were saved for immunoblotting with antibodies against STAT3, pSTAT3Y705, Akt, and pAktSer473. Signal intensity was normalized to actin. Statistical analysis was made using Student’s t-test.

Results: GATA-3 expression in Tregs was reduced in SLE as compared with HC (relative mean fluorescence intensity: 0.81±0.09, p=0.032) in freshly isolated CD3+ T cells, whereas IL-21 secretion appears to be increased in culture supernatants of SLE T cells (SLE: 415.37±207.62 pg/ml, HC: 147.38±45.28 pg/ml, p=0.10). Under Treg-polarizing conditions, IL-21 suppressed CD4+CD25+FOXP3+ Treg differentiation in SLE (frequency of CD4+CD25+FOXP3hi cells; control: 57.06±3.35%, IL-21-treated cells: 34.80±2.13%, p=0.0002) and HC (control: 45.30±6.66%, IL-21-treated cells: 30.43±2.84%, p=0.03). IL-21 suppressed GATA-3 expression in CD4+CD25+FOXP3+ Tregs in SLE (control 58.31±7.93%, IL-21-treated cells 26.57±5.40%, p=0.001) and HC (control: 59.53±5.32%, IL-21-treated cells: 38.47±8.51%, p=0.045). Mechanistically, IL-21 phosphorylated STAT3 (relative intensity: 1.48±0.19, p=0.033) as well as Akt (relative intensity: 1.48±0.20, p=0.037) in SLE CD4+T cells cultured under Treg-skewing conditions. Rapamycin suppressed IL-21 secretion by SLE T cells stimulated with anti-CD3/CD28 (control: 415.37±207.62 pg/ml, rapamycin: 8.23±3.01 pg/ml, p=0.047).

Conclusion: The data indicate that IL-21 phosphorylates STAT3 and Akt and inhibits Treg differentiation in SLE, possibly via the suppression of GATA-3. Suppression of T-cell IL-21 secretion emerges as one of the mechanisms by which rapamycin promotes Treg expansion in SLE.


Disclosure: H. Kato, None; A. Perl, None.

To cite this abstract in AMA style:

Kato H, Perl A. IL-21 Abrogates CD4+CD25+FOXP3+ Treg Differentiation in Part By Suppressing Treg GATA-3 Expression in SLE [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/il-21-abrogates-cd4cd25foxp3-treg-differentiation-in-part-by-suppressing-treg-gata-3-expression-in-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-21-abrogates-cd4cd25foxp3-treg-differentiation-in-part-by-suppressing-treg-gata-3-expression-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology